Press Release

May 4th, 2011

The new essential for every first aid kit – fast cooling relief for injury trauma and painful joints.

From primary school children to the elderly, a powerful new unique product, Traumitane™, is set to become an essential part of every household medicine cupboard and the sports bags of professionals Positioned to revolutionise the accessibility to fast, natural pain relief, Traumitane™ is a new triple action anti-inflammatory. It is a first call treatment, when an injury is sustained. It contains natural ingredients, combining key actives such as high strength arnica; glucosamine and menthol to help reduce inflammation.

Warwick Lightbourne, Founder and Principal of Clinical Technology, is excited to see Traumitane™ finally reach the market. “All our products are clinically developed. This is a long slow process but it means we know the end product helps to ease pain. When sports personalities won’t leave home without your products you know you must be doing something right.” Produced in New Zealand by Douglas Pharmaceuticals, this unique triple action rub has been years in development. It slows the progression of joint damage and provides an instant ice-cooling effect for injury, bruising, strains & sprains, aching nerves, muscles and joints.

Only available in pharmacies, the easy-use 75g tube contains one of the highest concentrations of arnica on the market, selling at a competitive recommended retail price of $19.90 Traumitane™ is easily absorbed into the skin, leaving no greasy residue or lingering smell. Ensuring rapid action while the cream keeps working for up to 24 hours.

Since 1983 Lightbourne has worked closely with patients at his Cornwall Injury Clinic in Auckland’s Greenlane. Traumitane™ is the latest sports support product developed by Lightbourne, since he founded Clinical Technology in 1999 to create high quality natural healthcare products for sports injuries, arthritis and pain relief. Clinical Technology has developed a research and development method that continues to extend its successful product portfolio. For example, the unique Clinical Technology injury supports, Thermastrap™ and Elastastrap™ are combined market leaders in the orthopedic field. Clinical Technology’s first products, Percutane™ Sports Action and Joint Action have a strong warming action and have a loyal customer base New Zealand wide, including Arthritis New Zealand and leading New Zealand sports individuals and teams. Traumitane™ now offers a new alternative for those seeking a strong fast acting, cooling recovery action. It is recommended for immediate application on injury, after arduous sport, or joint wear and tear.

Clinical Technology products are distributed by Douglas Pharmaceuticals locally. They are also exported to Australia, the UK and Scandinavia. A new website has been launched for further information and advice. www.traumitane.com

Ends.